Demographic Surveillance System Support in the Republic of Mozambique under the President's Emergency | CDC RFA GH17 1725

Opportunity Information: Apply for CDC RFA GH17 1725

The grant opportunity titled "Demographic Surveillance System Support in the Republic of Mozambique under the President's Emergency" (Funding Opportunity Number CDC RFA GH17-1725) is a U.S. Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH) cooperative agreement designed to strengthen demographic and public health surveillance capacity in Mozambique in the context of the HIV epidemic. The overall goal is to improve how Mozambique and its partners understand the on-the-ground public health context driving HIV transmission and outcomes, while also assessing how well HIV prevention and control programs are working. By improving the quality and usefulness of surveillance data, the program is intended to support smarter targeting of interventions, stronger program performance, and ultimately a reduction in HIV incidence in Mozambique. The opportunity is positioned within the President's Emergency framework, indicating alignment with U.S. emergency HIV response priorities and investments, and emphasizes practical, program-relevant surveillance rather than purely academic research.

This funding announcement is categorized as discretionary and uses a cooperative agreement as the funding instrument, which typically means the CDC expects to be substantially involved in the project beyond simply providing funds. The funded work falls under the "Health" activity category and is listed under CFDA number 93.067. The announcement describes a core emphasis on building public health capacity for surveillance, which generally includes developing or improving systems that can track demographic events and health indicators over time, improving data collection and data quality processes, strengthening analytic capacity, and ensuring findings are translated into actionable recommendations for HIV programs. A central theme is using surveillance to identify strengths and weaknesses in existing prevention and control activities, so programs can be adjusted based on evidence rather than assumptions.

Eligibility is broadly defined as unrestricted, meaning it is open to many entity types, with additional clarifications provided in the eligibility text. Eligible applicants span both government and non-government organizations. On the government side, eligibility includes state governments (including the District of Columbia), local governments, and U.S. territorial governments and their bona fide agents, as well as political subdivisions of states (in consultation with states). State-controlled institutions of higher education are also included. The eligibility list also references American Indian or Alaska Native tribal governments (federally recognized or state-recognized), as well as tribally designated organizations and other related entities such as Alaska Native health corporations, tribal epidemiology centers, and urban Indian health organizations. Importantly for an activity focused on Mozambique, "Ministries of Health" are explicitly identified as eligible under the "Other" category, signaling that national-level public health leadership bodies can be direct applicants where permitted.

Non-government eligibility is similarly expansive and includes nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education under those specific lines), colleges and universities, community-based organizations, faith-based organizations, hospitals, and research institutions as long as the activities they conduct under the award are deemed non-research. The FOA also allows for-profit organizations (other than small businesses) and explicitly notes small, minority-, and women-owned businesses, as well as an "All Other" category, reinforcing that CDC intended the competition to be fully open and competitive across a wide range of potential implementers. This wide eligibility suggests CDC was seeking the most capable applicant to run or support a robust surveillance platform, whether that capacity sits in government, academia, or an implementing partner with strong field operations and data systems expertise.

Key administrative details include an original closing date of 2017-01-25, a creation date of 2017-01-19, and an award ceiling listed at $800,000. The announcement notes "Expected Awards:" but does not provide a number in the provided source, which may mean the number of awards was either not specified in the excerpt or depended on available funds and application quality. Because the instrument is a cooperative agreement, prospective applicants would typically be expected to propose a work plan that is technically strong, feasible within the budget ceiling, and aligned with CDC priorities for surveillance, monitoring, and program improvement. The practical intent is clear: build or enhance demographic surveillance system support in Mozambique so HIV programs have better situational awareness, can identify gaps and underperforming areas, and can track whether prevention and treatment strategies are translating into measurable population-level improvements.

Taken together, the opportunity is best understood as a capacity-building and data-for-action investment aimed at strengthening Mozambique's ability to monitor demographic and health trends relevant to HIV, evaluate HIV program performance, and use evidence to improve intervention targeting. The anticipated public health payoff is not simply more data, but better decisions: stronger surveillance should lead to more efficient allocation of resources, more responsive HIV prevention and control strategies, and measurable progress toward reducing new HIV infections in Mozambique.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Demographic Surveillance System Support in the Republic of Mozambique under the President's Emergency" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2017-01-19.
• Applicants must submit their applications by 2017-01-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $800,000.00 in funding.
• Eligible applicants include: Others.

Apply for CDC RFA GH17 1725

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: